Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health reports developments tied to its healthcare services business for people with complex conditions. Company news commonly covers operating and financial results, customer activity with health plans and providers, and the Performance Suite contract model used in its specialty care operations.
Recurring updates also include Evolent's complex specialty care focus in oncology, cardiology and musculoskeletal conditions, management participation in healthcare investor conferences, leadership appointments, board and compensation matters, and equity-award disclosures under NYSE rules.
Evolent Health reported a 15.0% increase in GAAP revenue for Q4 2020, totaling $271.9 million, and a 20.8% increase for the full year, reaching $1.02 billion. The company posted a net loss of $(14.6) million for Q4 and $(334.2) million for the year. Adjusted EBITDA improved to $16.1 million for Q4 and $41.4 million for the year. Strategic growth was evident with new partnerships, such as with Blue Cross Blue Shield of Texas, bolstering their market position. Evolent aims for continued momentum in 2021, focusing on capital allocation and operational efficiencies.
Evolent Health (NYSE: EVH) announced that CEO Seth Blackley and CFO John Johnson will participate in the Cowen 41st Annual Health Care Conference. Their virtual presentation is scheduled for March 3, 2021, at 3:20 p.m. ET. A live audio webcast will be available on Evolent's investor relations site. Evolent Health focuses on delivering clinical and administrative solutions to enhance whole-person health. The company is recognized for its innovative cost management and has received the NCQA Population Health Program Accreditation.
Evolent Health (NYSE: EVH) will announce its fourth quarter and full year 2020 operating results on February 25, 2021, after market close. A conference call will follow at 5:00 p.m. Eastern Time, where shareholders and participants can dial in to listen. The company offers clinical and administrative solutions to improve health care efficiency. Evolent has received the National Committee for Quality Assurance's Population Health Program Accreditation and is recognized as a leading workplace in health care.
Evolent Health (NYSE: EVH) announced the appointment of Kim A. Keck to its Board of Directors, effective immediately. Keck, with over 30 years of health care experience, replaces retiring board member Bruce Felt. As President and CEO of the Blue Cross Blue Shield Association, she brings valuable insights to Evolent during a critical growth phase. The company also named Cheryl Scott as Lead Independent Director. Evolent aims to enhance its clinical and administrative solutions while maximizing shareholder value.
Evolent Health (NYSE: EVH) has announced a definitive agreement with Bright HealthCare to acquire True Health New Mexico, a wholly-owned subsidiary of Evolent. The transaction, expected to close in the first half of 2021, aims to enhance Evolent's operational framework, while continuing to provide health plan support to True Health New Mexico. Evolent's CEO, Seth Blackley, highlighted the focus on creating shareholder value through organic revenue growth and margin expansion. Current employees of True Health New Mexico will join Bright HealthCare, ensuring continuity in market operations.
Evolent Health (NYSE: EVH) announced a Cooperation Agreement with Engaged Capital, appointing Craig Barbarosh to its Board of Directors as a Class III director. A Strategy Committee will be created to enhance operational efficiency and financial performance. Evolent also plans to amend its Charter to declassify the Board, allowing directors to stand for one-year terms post-2021 Annual Meeting. Engaged Capital emphasizes its commitment to maximizing shareholder value. This move aims to strengthen governance and strategic direction for Evolent's future.
Evolent Health (NYSE: EVH) announced participation in the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021. CEO Seth Blackley and CFO John Johnson will present virtually at 9:10 a.m. ET. A live audio-only webcast will be accessible via Evolent's investor relations page.
Evolent Health provides clinical and administrative solutions that enhance health care efficiency and affordability, serving leading payers and providers nationwide. The company has received national recognition for its population health programs and work environment.
Evolent Health, a leading health care solutions provider, announced that CEO Seth Blackley and CFO John Johnson will participate in 1x1 meetings at the 32nd Annual Piper Sandler Healthcare Conference on December 2, 2020. Meetings can be arranged through Piper Sandler. Evolent focuses on improving health care affordability and delivery with a range of services, including total cost of care management. The company has received national recognition for its innovative approach and workplace environment.
Summary not available.
Evolent Health (NYSE: EVH) has partnered with Florida Blue Medicare to provide comprehensive oncology specialty management services through its subsidiary, New Century Health. This collaboration aims to manage the cost and quality of oncology care for 125,000 Medicare Advantage members across Florida's network of 1,000 physicians in 67 counties. The initiative focuses on evidence-based clinical pathways and aligned payment models to enhance patient outcomes and reduce costs. Full health plan operations are set to begin on January 1, 2021.